2395 — Shin Nippon Biomedical Laboratories Cashflow Statement
0.000.00%
Last trade - 00:00
- ¥53bn
- ¥69bn
- ¥26bn
- 51
- 66
- 18
- 39
2020 March 31st | 2021 March 31st | 2022 March 31st | 2023 March 31st | 2024 March 31st | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | Yuho | Yuho | Yuho | Yuho | Yuho |
Standards: | JAS | JAS | JAS | JAS | JAS |
Status: | Final | Final | Final | Final | Final |
Net Income/Starting Line | 3,063 | 4,176 | 8,183 | 7,760 | 6,974 |
Depreciation | |||||
Amortisation | |||||
Non-Cash Items | -381 | -1,512 | -3,805 | -2,574 | -3,120 |
Unusual Items | |||||
Equity in Net Earnings/Losses | |||||
Other Non-Cash Items | |||||
Changes in Working Capital | -892 | 896 | 397 | -2,784 | -3,616 |
Change in Accounts Receivable | |||||
Change in Inventories | |||||
Change in Accounts Payable | |||||
Change in Other Liabilities | |||||
Other Operating Cash Flow | |||||
Cash from Operating Activities | 3,018 | 4,747 | 5,953 | 4,002 | 2,107 |
Capital Expenditures | -1,230 | -1,118 | -1,614 | -4,956 | -8,605 |
Purchase of Fixed Assets | |||||
Purchase / Acquisition of Intangibles | |||||
Other Investing Cash Flow Items | -225 | 849 | -2,654 | -975 | 1,698 |
Acquisition of Business | |||||
Sale of Business | |||||
Sale of Fixed Assets | |||||
Sale/Maturity of Investment | |||||
Purchase of Investments | |||||
Other Investing Cash Flow | |||||
Cash from Investing Activities | -1,455 | -269 | -4,269 | -5,931 | -6,908 |
Financing Cash Flow Items | -70.8 | -6.6 | -2.95 | 33.9 | -2.95 |
Other Financing Cash Flow | |||||
Total Cash Dividends Paid | |||||
Net Issuance / Retirement of Stock | |||||
Net Issuance / Retirement of Debt | |||||
Cash from Financing Activities | -1,450 | -2,471 | -4,912 | 6,266 | 5,319 |
Foreign Exchange Effects | |||||
Beginning Cash Balance | |||||
Ending Cash Balance | |||||
Net Change in Cash | 109 | 2,037 | -2,731 | 4,649 | 1,077 |